BDNF and depressive disorder: In summary, we propose that it should be critically considered that there are methodological and hypothetical differences between the studies: (1) the regulatory impact of miRNAs on BDNF expression in the brain needs to be strongly considered in the development of therapeutic treatments for neurodegenerative diseases and depression.